GC
BMY icon

GFG Capital’s Bristol-Myers Squibb BMY Stock Holding History

GFG Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,996
Closed -$422K – 117
2020
Q3 		$422K Hold
6,996
– – 0.16% 65
2020
Q2 		$411K Sell
6,996
-158
-2% -$9.45K 0.18% 72
2020
Q1 		$399K Sell
7,154
-77
-1% -$4.71K 0.2% 54
2019
Q4 		$464K Buy
+7,231
New +$414K 0.2% 55

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GFG Capital's BMY Position: Q4 2020 in Review

GFG Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 6,996 shares — an estimated $422K sold.

GFG Capital first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $464K in Q4 2019. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • GFG Capital reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • GFG Capital sold 6,996 Bristol-Myers Squibb shares in Q4 2020, an estimated $422K.
  • GFG Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
  • GFG Capital's Bristol-Myers Squibb position peaked at $464K in Q4 2019.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on GFG Capital's 13F filing for Q4 2020, filed 28 Jan 2021.